Norbrook To Give Ageing Dogs A New Lease Of Life

Leading veterinary pharmaceuticals manufacturer, Norbrook Laboratories Ltd has just launched a new product for their small animal range. Propentofylline for dogs is the latest addition from Norbrook for the treatment of a range of ailments in ageing dogs. “We launched Propentofylline to the UK market at the recent VPMA Congress where it was warmly received by the delegates with plenty of positive comments on both the lively design of the campaign and the opportunities for use of this product in practice.,” comments Ms Michelle Jones, Norbrook Laboratories Ltd, Brand Manager, Small Animal. “The product is indicated for improving dullness, lethargy and general demeanour in dogs to essentially give them a new lease of life.” Available in 50mg and 100mg tablets Propentofylline can be prescribed to help boost a dog’s willingness to exercise and improve exercise tolerance. Speaking at the launch of the product at the VPMA Congress, Ms Pauline Graham, VPMA President and Capontree Vets commented: “Propentofylline, as an active ingredient, is widely prescribed by vets with its properties that assist increased blood flow, particularly to the heart and skeletal muscle. Also increasing the blood flow to the brain and therefore its oxygen supply, it is a well recognised treatment for older, lethargic dogs to help encourage brightness as well as tolerance and willingness to exercise. I am pleased to see Norbrook offering this product as another high quality and cost effective addition to their small animal range.” Norbrook’s Propentofylline Tablets is now available to Veterinary Practices. “Veterinary practices can avail of a range of promotional support material for our Propentofylline product including a technical brochure and waiting room posters,” adds Ms Jones. “We will have an introductory offer which our Territory Managers will be pleased to discuss with their clients.” Propentofylline Tablets joins Norbrook’s small animal range which includes Loxicom for cats and dogs, a meloxicam product available as an oral suspension or an injectable, Carprieve, a carprofen product available as an injectable for dogs and cats and in tablet form for dogs and the recently launched Noroquin which is a glucosamine based supplement for cats, dogs and horses.

More from

• IVC Evidensia assembles expert team to run new £10m referral hospital
• Home delivery service can increase pet health plan sign-ups by 25%
• Research reveals vital clues to help fight anthelmintic resistance
• Lifetime Achievement Award recognises Harrogate vet’s dedication to improving the health and welfare of rabbits
• Bake sale at Leicestershire vet practice for good cause